KR102671524B1 - 구역 반사의 치료를 위한 조성물 및 요법 - Google Patents

구역 반사의 치료를 위한 조성물 및 요법 Download PDF

Info

Publication number
KR102671524B1
KR102671524B1 KR1020227025334A KR20227025334A KR102671524B1 KR 102671524 B1 KR102671524 B1 KR 102671524B1 KR 1020227025334 A KR1020227025334 A KR 1020227025334A KR 20227025334 A KR20227025334 A KR 20227025334A KR 102671524 B1 KR102671524 B1 KR 102671524B1
Authority
KR
South Korea
Prior art keywords
composition
patient
sodium chloride
volume
gag reflex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020227025334A
Other languages
English (en)
Korean (ko)
Other versions
KR20220122680A (ko
Inventor
웨인 프로보스트
로버트 올슨
데쉬카 올슨
Original Assignee
오리온 이노베이션스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오리온 이노베이션스 인코포레이티드 filed Critical 오리온 이노베이션스 인코포레이티드
Publication of KR20220122680A publication Critical patent/KR20220122680A/ko
Application granted granted Critical
Publication of KR102671524B1 publication Critical patent/KR102671524B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020227025334A 2019-12-30 2020-12-11 구역 반사의 치료를 위한 조성물 및 요법 Active KR102671524B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962954966P 2019-12-30 2019-12-30
US62/954,966 2019-12-30
US17/100,677 US20210196748A1 (en) 2019-12-30 2020-11-20 Composition and therapy for treatment of gag reflexes
US17/100,677 2020-11-20
PCT/US2020/064604 WO2021138025A1 (en) 2019-12-30 2020-12-11 Composition and therapy for treatment of gag reflexes

Publications (2)

Publication Number Publication Date
KR20220122680A KR20220122680A (ko) 2022-09-02
KR102671524B1 true KR102671524B1 (ko) 2024-05-31

Family

ID=76545400

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227025334A Active KR102671524B1 (ko) 2019-12-30 2020-12-11 구역 반사의 치료를 위한 조성물 및 요법

Country Status (7)

Country Link
US (5) US20210196748A1 (https=)
EP (1) EP4084869A4 (https=)
JP (3) JP7492772B2 (https=)
KR (1) KR102671524B1 (https=)
AU (1) AU2020417185B2 (https=)
BR (1) BR112022012998A2 (https=)
WO (1) WO2021138025A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210196748A1 (en) * 2019-12-30 2021-07-01 Robert Olson Composition and therapy for treatment of gag reflexes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210069097A1 (en) 2019-03-14 2021-03-11 Glen D. Lindbo Avoiding gag reflex to enable swallowing pills

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB954241A (en) * 1961-05-11 1964-04-02 Koopmans Meelfabrieken N V Process for the production of ready-for-use soups and sauces in powdered form
ZA73467B (en) * 1972-02-25 1973-10-31 Hoffmann La Roche Mineral salts containing preparation
US4068006A (en) * 1976-10-07 1978-01-10 Akzona Incorporated Salt seasoning mixture
US4414198A (en) * 1982-04-23 1983-11-08 Joseph Michaelson Rapidly disintegrable tablet composition and method
US4634591A (en) * 1985-09-06 1987-01-06 Westerman Robert D Anti-gagging compositions and method of treating gagging reflexes
DE10015662A1 (de) * 2000-03-29 2001-10-04 Henkel Kgaa Zahnpflegemittel in Portionskapseln
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
US20050019277A1 (en) * 2002-09-11 2005-01-27 The Procter & Gamble Company Tooth whitening products
US7989016B2 (en) * 2006-10-05 2011-08-02 Sambasiva Rao Chigurupati Method for producing a low sodium salt composition
RU2345773C2 (ru) * 2007-01-30 2009-02-10 ФГУ Новосибирский научно-исследовательский институт травматологии и ортопедии (ФГУ ННИИТО Росздрава) Способ ингаляционной анестезии с минимальным газотоком
US20120088971A1 (en) * 2008-03-19 2012-04-12 Hanu Surgical Devices Llc ROTICAM: An Orotracheal Guide with Camera
CA2893780A1 (en) * 2008-04-15 2009-10-22 Trudell Medical International Swallowing air pulse therapy mouthpiece and method for the use thereof
US10556011B2 (en) * 2011-12-02 2020-02-11 Joshua D. Levine Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen
PL3473248T3 (pl) * 2012-09-11 2022-07-25 Norgine Bv Kompozycje zawierające glikol polietylenowy i siarczany metali alkalicznych lub metali ziem alkalicznych do zastosowania jako kompozycje do oczyszczania jelita grubego
US20140335153A1 (en) * 2013-05-09 2014-11-13 Cure Pharmaceutical Corporation Thin film with high load of active ingredient
EP3131433A1 (en) * 2014-05-07 2017-02-22 Colgate-Palmolive Company Oral care system
US20160271120A1 (en) * 2015-03-17 2016-09-22 Oakdene Holdings Llc Pharmaceutical composition for cleansing of the gastrointestinal tract
CN106420810A (zh) * 2016-09-27 2017-02-22 天津市聚星康华医药科技有限公司 一种补液盐口腔溶解膜及其制备方法
CN108354068A (zh) * 2018-05-24 2018-08-03 张继成 一种多功能畜禽补水溶液及其制备方法
KR102245629B1 (ko) * 2019-04-10 2021-04-30 주식회사 제네웰 히알루론산계 녹는 필름, 이의 제조방법 및 이에 사용되는 이형지
US20210196748A1 (en) * 2019-12-30 2021-07-01 Robert Olson Composition and therapy for treatment of gag reflexes
CN112042908A (zh) * 2020-09-14 2020-12-08 湖南雨泉农业发展有限公司 一种无糖保健型葛粉果冻及其制作方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210069097A1 (en) 2019-03-14 2021-03-11 Glen D. Lindbo Avoiding gag reflex to enable swallowing pills

Also Published As

Publication number Publication date
WO2021138025A1 (en) 2021-07-08
AU2020417185B2 (en) 2026-03-12
JP2024105427A (ja) 2024-08-06
JP7492772B2 (ja) 2024-05-30
US20230025472A1 (en) 2023-01-26
JP2023516851A (ja) 2023-04-21
US11813286B2 (en) 2023-11-14
EP4084869A1 (en) 2022-11-09
BR112022012998A2 (pt) 2022-09-06
US11701383B2 (en) 2023-07-18
AU2020417185A1 (en) 2022-07-21
US20210260105A1 (en) 2021-08-26
US20230024303A1 (en) 2023-01-26
US20230414652A1 (en) 2023-12-28
KR20220122680A (ko) 2022-09-02
US20210196748A1 (en) 2021-07-01
CA3163259A1 (en) 2021-07-08
EP4084869A4 (en) 2024-02-14
US11458162B2 (en) 2022-10-04
JP2025166003A (ja) 2025-11-05
JP7724579B2 (ja) 2025-08-18

Similar Documents

Publication Publication Date Title
Lee Recent advances in topical anesthesia
AU1657201A (en) Therapeutic compositions and methods of use thereof
CA2434484A1 (en) Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances
JP2017527608A (ja) 経鼻組成物と該経鼻組成物の使用方法の改善
MX2024015351A (es) Composicion farmaceutica para tratar y resistir a la coagulacion sanguinea y uso de la misma
JP2025166003A (ja) 咽頭反射の処置のための組成物および治療
Nakamura et al. A new method of topical anesthesia by using anesthetic solution in a patch
US12458607B2 (en) Adhesive pad
CN107582536A (zh) 一种枸橼酸铋钾口腔粘贴片及其制备方法
JPWO2008120562A1 (ja) 帯状疱疹後神経痛治療用錠剤および帯状疱疹後神経痛の治療方法
CA3163259C (en) Composition and therapy for treatment of gag reflexes
Syrjänen et al. A new combination of drugs intended to be used as a preventive measure for the postextraction complications: A preliminary report
AU2015305430A1 (en) Method for treating hyperhidrosis
Srinivasan et al. Topical drugs for pain relief
CN117257886A (zh) 一种跌打损伤组合物外用制剂及其制备方法和应用
İlaçlar Arşiv Kaynak Tarama Dergisi
CN101919799A (zh) 新型缓释透皮给药系统
CN101721457A (zh) 一种治疗口腔溃疡病的药物
Mahlovanyy et al. Lviv 2015
Jaffe et al. A Multicentric Open Assessment of Fortagesic
CN108653394A (zh) 一种治疗口腔溃疡的药物配方
CN109394971A (zh) 一种治疗牙痛、口腔溃疡及带状疱疹的中药配方
RS54912B1 (sr) Farmaceutske formulacije tiokolhikozida sa produženim oslobađanjem

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20220720

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240115

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20240327

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20240529

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20240529

End annual number: 3

Start annual number: 1

PG1601 Publication of registration